Blog articles

Cancer therapy involving genome editing cures another child’s leukaemia
We look at a new type of CAR-T cell therapy that, in the world’s first use, has cured a child patient’s leukaemia

Looking back: Genomics in 2022 (part one)
In the first of our two-part round-up of 2022, we look back at some of this year's most exciting clinical developments in genomics

How can genomics combat doxorubicin-induced cardiotoxicity?
This week, we examine the role that genomics could play in reducing the number of child cancer patients who experience doxorubicin-induced cardiotoxicity

Motor neurone disease: Could gene therapies be the answer?
New clinical studies hope to use genomics to improve treatment of and even find a cure for motor neurone disease

Haemophilia: Have we found a cure?
A new gene therapy for treating this rare condition has shown success at clinical trial

Reducing stroke risk with a genetic test
NHS Tayside introduces UK's first routine genetic test for stroke patients, estimated to bring improved outcomes to thousands of patients each year

Lupus and the genome
A groundbreaking study has shed light on how some people may inherit autoimmune conditions

Inversions explained
We dive into inversions, how they impact on health and what new research has revealed about their role in the genome

Diverse genomic study pinpoints Covid-19 variant
Sometimes data diversity can make the difference. We look at findings from a new Covid-19 study to find out how
News articles

New genomics learning gateway for pharmacy workforce
Pharmacy professionals are invited to start their genomics learning journey with this handy new learning portal

Genomics course for nurses and midwives: funded places now available
Nurses and midwives keen to learn about genomics can apply to join this popular introductory course delivered online by the University of the West of England
Events

LinkAGE Webinar 2: CRISPR
Welcome to the second of our new series of expert webinars. In this second webinar Dr James Patterson will discuss CRISPR.